tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

NRXP Stock Latest News

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Announce Potential Acquisition and Financing Agreements for $30 Million in Currently-Operating Interventional Psychiatry Clinics
Press ReleasesHOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Announce Potential Acquisition and Financing Agreements for $30 Million in Currently-Operating Interventional Psychiatry Clinics
25d ago
NRXP
NRX Pharmaceuticals Seeks New CEO for Drug Launches
PremiumCompany Announcements
NRX Pharmaceuticals Seeks New CEO for Drug Launches
1M ago
8K
NRXP
NRx Pharmaceuticals reports Q2 net loss $7.9M vs. $8.7M last year
PremiumThe Fly
NRx Pharmaceuticals reports Q2 net loss $7.9M vs. $8.7M last year
1M ago
NRXP
NRx Pharmaceuticals (NASDAQ:NRXP) Reports Second Quarter and Year to Date 2024 Financial Results and Provides Business Update
PremiumPress Releases
NRx Pharmaceuticals (NASDAQ:NRXP) Reports Second Quarter and Year to Date 2024 Financial Results and Provides Business Update
1M ago
NRXP
NRx Pharmaceuticals target adjusted to $19 from $2 at H.C. Wainwright
PremiumThe Fly
NRx Pharmaceuticals target adjusted to $19 from $2 at H.C. Wainwright
2M ago
NRXP
NRx Pharmaceuticals announces alignment with FDA on study plan for NRX-100
PremiumThe FlyNRx Pharmaceuticals announces alignment with FDA on study plan for NRX-100
2M ago
NRXP
NRx Pharmaceuticals’ spinoff of Hope Therapeutics enabled by arbitration order
Premium
The Fly
NRx Pharmaceuticals’ spinoff of Hope Therapeutics enabled by arbitration order
2M ago
NRXP
NRx Pharmaceuticals publishes shareholder update letter
Premium
The Fly
NRx Pharmaceuticals publishes shareholder update letter
3M ago
NRXP
NRx Pharmaceuticals (NASDAQ:NRXP) Publishes Shareholder Update Letter
PremiumPress Releases
NRx Pharmaceuticals (NASDAQ:NRXP) Publishes Shareholder Update Letter
3M ago
NRXP
NRx Pharmaceuticals to proceed with two new NDAs in 2024
PremiumThe Fly
NRx Pharmaceuticals to proceed with two new NDAs in 2024
3M ago
NRXP
NRX Pharmaceuticals Faces Agreement Termination, Eyes Accelerated Approval
PremiumCompany Announcements
NRX Pharmaceuticals Faces Agreement Termination, Eyes Accelerated Approval
3M ago
8K
NRXP
NRx Pharmaceuticals’ NRX-101 eeduces suicidality in bipolar depression trial
PremiumThe Fly
NRx Pharmaceuticals’ NRX-101 eeduces suicidality in bipolar depression trial
4M ago
NRXP
NRX Pharmaceuticals Eyes $30M Refinancing and Funding Deal
PremiumCompany AnnouncementsNRX Pharmaceuticals Eyes $30M Refinancing and Funding Deal
4M ago
8K
NRXP
NRx Pharmaceuticals (Nasdaq:NRXP) Reports First Quarter 2024 Financial Results and Provides Business Update
Premium
Press Releases
NRx Pharmaceuticals (Nasdaq:NRXP) Reports First Quarter 2024 Financial Results and Provides Business Update
4M ago
NRXP
NRx Pharmaceuticals reports final trial results of NRX-101
Premium
The Fly
NRx Pharmaceuticals reports final trial results of NRX-101
5M ago
NRXP
NRx Pharmaceuticals’ NRX-101 shows efficacy in Phase 2b/3 depression trial
PremiumThe Fly
NRx Pharmaceuticals’ NRX-101 shows efficacy in Phase 2b/3 depression trial
5M ago
NRXP
NRx Pharmaceuticals prices $2M public offering at $3.30 per share
PremiumThe Fly
NRx Pharmaceuticals prices $2M public offering at $3.30 per share
5M ago
NRXP
NRx Pharmaceuticals demonstrates compliance with Nasdaq bid price rule
PremiumThe Fly
NRx Pharmaceuticals demonstrates compliance with Nasdaq bid price rule
5M ago
NRXP
NRx Pharmaceuticals announces common stock offering, no amount given
PremiumThe Fly
NRx Pharmaceuticals announces common stock offering, no amount given
5M ago
NRXP
NRx Pharmaceuticals announces new data on NRX-101
PremiumThe FlyNRx Pharmaceuticals announces new data on NRX-101
5M ago
NRXP
NRx Pharmaceuticals develops new proprietary formulation of HTX-100
Premium
The Fly
NRx Pharmaceuticals develops new proprietary formulation of HTX-100
5M ago
NRXP
NRx Pharmaceuticals achieves data-lock of Phase 2b/3 trial of NRX-101
Premium
The Fly
NRx Pharmaceuticals achieves data-lock of Phase 2b/3 trial of NRX-101
5M ago
NRXP

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >